Pulsenmore is a world leader in portable ultrasound devices for home use and is the first to enable patients to self-scan for remote clinical assessment.

The company was founded in 2014 by its CEO, Dr. Elazar Sonnenschein, and aims to make home ultrasound universally accessible for remote and reliable care.

The flagship product for fetal ultrasound is approved for marketing in Europe (CE) and in Israel. Clinical studies in the U.S. are currently underway.

Pulsenmore is traded on the Tel Aviv Stock Exchange (TASE: PULS).


Leave a Reply